共 4 条
[3]
An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome. Kellow J,Lee O Y,Chang F Y,Thongsawat S,Mazlam M Z,Yuen H,Gwee K A,Bak Y T,Jones J,Wagner A. Gut . 2003
[4]
A randomized controlled trial of a probiotic,VSL#3,on gut transit and symptoms in diarrhoea-predominant irritahle bowel syndrome. Kim HJ,Camilleri M,McKinzie S,Lempke MB,Burton DD,Thomforde GM,Zinsmeister AR. Alimentary Pharmacology and Therapeutics . 2003